SMTL ID : 9dnw.1

Human ClC-3:noTMEM9

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

homo-dimer

Ligands

4 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 8 residues within 4Å: Chain A: G.280, K.281, E.282, G.283, P.284, G.525, F.527, I.528 Ligand excluded by PLIP CL.2: 8 residues within 4Å: Chain A: S.239, I.241, G.283, P.284, G.525, L.526, F.527, Y.630 Ligand excluded by PLIP CL.6: 8 residues within 4Å: Chain B: G.280, K.281, E.282, G.283, P.284, G.525, F.527, I.528 Ligand excluded by PLIP CL.7: 9 residues within 4Å: Chain B: S.239, I.241, G.283, P.284, F.518, G.525, L.526, F.527, Y.630 Ligand excluded by PLIP

4 x CLR: CHOLESTEROL(Non-covalent)

CLR.3: 8 residues within 4Å: Chain A: L.134, L.137, A.138, A.141, F.296, V.362, S.365, I.366 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.137, A:A.141, A:F.296, A:F.296, A:I.366 CLR.4: 12 residues within 4Å: Chain A: W.152, M.153, L.156, I.160, L.162, L.165, W.193, L.196, W.217, F.221, L.224, L.271 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:W.152, A:L.156, A:I.160, A:L.162, A:W.193, A:W.193, A:W.217, A:W.217, A:F.221, A:L.224 CLR.8: 8 residues within 4Å: Chain B: L.134, L.137, A.138, A.141, F.296, V.362, S.365, I.366 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:L.137, B:A.141, B:F.296, B:F.296, B:I.366 CLR.9: 12 residues within 4Å: Chain B: W.152, M.153, L.156, I.160, L.162, L.165, W.193, L.196, W.217, F.221, L.224, L.271 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:W.152, B:L.156, B:I.160, B:L.162, B:W.193, B:W.217, B:W.217, B:F.221, B:L.224

2 x 01: (2R)-1-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}-3-(octadecanoyloxy)propan-2-yl (5E,8E,11E,13E)-icosa-5,8,11,13-tetraenoate

01.5: 18 residues within 4Å: Chain A: L.142, L.145, I.253, R.254, G.255, Y.256, L.257, G.258, K.259, W.260, L.262, M.263, T.266, I.267, N.294, I.295, Y.298, K.310 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:L.142, A:L.145, A:K.259, A:W.260, A:W.260, A:L.262, A:M.263, A:I.267 Hydrogen bonds: A:I.253, A:R.254, A:G.255, A:K.259, A:K.259, A:W.260, A:N.294, A:Y.298, A:Y.298 Salt bridges: A:K.259, A:K.259, A:K.310 01.10: 17 residues within 4Å: Chain B: L.142, L.145, I.253, R.254, G.255, Y.256, L.257, G.258, K.259, W.260, L.262, M.263, T.266, I.267, N.294, I.295, Y.298 19 PLIP interactions: 19 interactions with chain B Hydrophobic interactions: B:L.142, B:L.145, B:K.259, B:W.260, B:W.260, B:L.262, B:M.263, B:I.267 Hydrogen bonds: B:I.253, B:R.254, B:G.255, B:K.259, B:K.259, B:W.260, B:N.294, B:Y.298, B:Y.298 Salt bridges: B:K.259, B:K.259

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schrecker, M. et al., Structural basis of ClC-3 inhibition by TMEM9 and PI(3,5)P 2. Biorxiv (2025)

Release Date

2025-04-02

Peptides

H(+)/Cl(-) exchange transporter 3: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

H(+)/Cl(-) exchange transporter 3

Related Entries With Identical Sequence